Back
Columbia Research Enhanced Value ETF Vs. MoonLake Immunotherapeutics Industry Stock Comparison
Buy
60
REVS
Columbia Research Enhanced Value ETF
Last Price:
24.93
Seasonality Move:
4.3%
Buy
83
MLTX
MoonLake Immunotherapeutics
Last Price:
53.18
Seasonality Move:
10.4%
Buy
60
Columbia Research Enhanced Value ETF (REVS)
is a Buy
Is Columbia Research Enhanced Value ETF a Buy, Sell or Hold?
- The current Columbia Research Enhanced Value ETF [REVS] share price is $24.93. The Score for REVS is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- REVS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
83
MoonLake Immunotherapeutics (MLTX)
is a Buy
Is MoonLake Immunotherapeutics a Buy, Sell or Hold?
- The current MoonLake Immunotherapeutics [MLTX] share price is $53.02. The Score for MLTX is 83, which is 66% above its historic median score of 50, and infers lower risk than normal.
- MLTX is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
REVS Stock Price Chart
What is Columbia Research Enhanced Value ETF's stock price today?
-
The Columbia Research Enhanced Value ETF share price today is $24.93
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and REVS is experiencing selling pressure, which indicates risk of future bearish movement.
MLTX Stock Price Chart
What is MoonLake Immunotherapeutics's stock price today?
-
The MoonLake Immunotherapeutics share price today is $53.02
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MLTX is experiencing slight selling pressure.
REVS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.16 | Buy |
Relative Strength Index (14 RSI): | 60.14 | Buy |
Chaikin Money Flow: | -3078 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (24.36 - 24.94) | Buy |
Bollinger Bands (100): | (23.15 - 24.43) | Buy |
MLTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.36 | Buy |
Relative Strength Index (14 RSI): | 67.83 | Buy |
Chaikin Money Flow: | -49117 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (46.38 - 50.14) | Buy |
Bollinger Bands (100): | (40.67 - 47.33) | Buy |
REVS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 24.68 | Buy |
20-day SMA: | 24.75 | Buy |
50-day SMA: | 24.29 | Buy |
200-day SMA: | 23.07 | Buy |
8-day EMA: | 24.78 | Buy |
20-day EMA: | 24.64 | Buy |
50-day EMA: | 24.3 | Buy |
200-day EMA: | 23.14 | Buy |
MLTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 49.49 | Buy |
20-day SMA: | 48.24 | Buy |
50-day SMA: | 46.5 | Buy |
200-day SMA: | 48.46 | Buy |
8-day EMA: | 50.08 | Buy |
20-day EMA: | 48.49 | Buy |
50-day EMA: | 46.7 | Buy |
200-day EMA: | 45.76 | Buy |
Columbia Research Enhanced Value ETF Earnings Growth & REVS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
MoonLake Immunotherapeutics Earnings Growth & MLTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.21 per share, a decrease next quarter of $0.20 per share, a decrease this year of $0.64 per share, and a decrease next year of $0.79 per share.
Columbia Research Enhanced Value ETF Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
MoonLake Immunotherapeutics Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |